The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes

Abstract Epithelial ovarian cancer (EOC) is a highly lethal gynecologic malignancy arising from the fallopian tubes that has a high rate of chemoresistant recurrence and low five-year survival rate. The ovarian cancer biomarker HE4 is known to promote proliferation, metastasis, chemoresistance, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nicole E. James, Jenna B. Emerson, Ashley D. Borgstadt, Lindsey Beffa, Matthew T. Oliver, Virginia Hovanesian, Anze Urh, Rakesh K. Singh, Rachael Rowswell-Turner, Paul A. DiSilvestro, Joyce Ou, Richard G. Moore, Jennifer R. Ribeiro
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1e2034decd7b4213a5c0a5824478d5c9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e2034decd7b4213a5c0a5824478d5c9
record_format dspace
spelling oai:doaj.org-article:1e2034decd7b4213a5c0a5824478d5c92021-12-02T14:58:45ZThe biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes10.1038/s41598-020-65353-x2045-2322https://doaj.org/article/1e2034decd7b4213a5c0a5824478d5c92020-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-65353-xhttps://doaj.org/toc/2045-2322Abstract Epithelial ovarian cancer (EOC) is a highly lethal gynecologic malignancy arising from the fallopian tubes that has a high rate of chemoresistant recurrence and low five-year survival rate. The ovarian cancer biomarker HE4 is known to promote proliferation, metastasis, chemoresistance, and suppression of cytotoxic lymphocytes. In this study, we sought to examine the effects of HE4 on signaling within diverse cell types that compose the tumor microenvironment. HE4 was found to activate STAT3 signaling and promote upregulation of the pro-angiogenic STAT3 target genes IL8 and HIF1A in immune cells, ovarian cancer cells, and endothelial cells. Moreover, HE4 promoted increases in tube formation in an in vitro model of angiogenesis, which was also dependent upon STAT3 signaling. Clinically, HE4 and IL8 levels positively correlated in ovarian cancer patient tissue. Furthermore, HE4 serum levels correlated with microvascular density in EOC tissue and inversely correlated with cytotoxic T cell infiltration, suggesting that HE4 may cause deregulated blood vessel formation and suppress proper T cell trafficking in tumors. Collectively, this study shows for the first time that HE4 has the ability to affect signaling events and gene expression in multiple cell types of the tumor microenvironment, which could contribute to angiogenesis and altered immunogenic responses in ovarian cancer.Nicole E. JamesJenna B. EmersonAshley D. BorgstadtLindsey BeffaMatthew T. OliverVirginia HovanesianAnze UrhRakesh K. SinghRachael Rowswell-TurnerPaul A. DiSilvestroJoyce OuRichard G. MooreJennifer R. RibeiroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nicole E. James
Jenna B. Emerson
Ashley D. Borgstadt
Lindsey Beffa
Matthew T. Oliver
Virginia Hovanesian
Anze Urh
Rakesh K. Singh
Rachael Rowswell-Turner
Paul A. DiSilvestro
Joyce Ou
Richard G. Moore
Jennifer R. Ribeiro
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
description Abstract Epithelial ovarian cancer (EOC) is a highly lethal gynecologic malignancy arising from the fallopian tubes that has a high rate of chemoresistant recurrence and low five-year survival rate. The ovarian cancer biomarker HE4 is known to promote proliferation, metastasis, chemoresistance, and suppression of cytotoxic lymphocytes. In this study, we sought to examine the effects of HE4 on signaling within diverse cell types that compose the tumor microenvironment. HE4 was found to activate STAT3 signaling and promote upregulation of the pro-angiogenic STAT3 target genes IL8 and HIF1A in immune cells, ovarian cancer cells, and endothelial cells. Moreover, HE4 promoted increases in tube formation in an in vitro model of angiogenesis, which was also dependent upon STAT3 signaling. Clinically, HE4 and IL8 levels positively correlated in ovarian cancer patient tissue. Furthermore, HE4 serum levels correlated with microvascular density in EOC tissue and inversely correlated with cytotoxic T cell infiltration, suggesting that HE4 may cause deregulated blood vessel formation and suppress proper T cell trafficking in tumors. Collectively, this study shows for the first time that HE4 has the ability to affect signaling events and gene expression in multiple cell types of the tumor microenvironment, which could contribute to angiogenesis and altered immunogenic responses in ovarian cancer.
format article
author Nicole E. James
Jenna B. Emerson
Ashley D. Borgstadt
Lindsey Beffa
Matthew T. Oliver
Virginia Hovanesian
Anze Urh
Rakesh K. Singh
Rachael Rowswell-Turner
Paul A. DiSilvestro
Joyce Ou
Richard G. Moore
Jennifer R. Ribeiro
author_facet Nicole E. James
Jenna B. Emerson
Ashley D. Borgstadt
Lindsey Beffa
Matthew T. Oliver
Virginia Hovanesian
Anze Urh
Rakesh K. Singh
Rachael Rowswell-Turner
Paul A. DiSilvestro
Joyce Ou
Richard G. Moore
Jennifer R. Ribeiro
author_sort Nicole E. James
title The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
title_short The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
title_full The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
title_fullStr The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
title_full_unstemmed The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
title_sort biomarker he4 (wfdc2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of stat3 target genes
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/1e2034decd7b4213a5c0a5824478d5c9
work_keys_str_mv AT nicoleejames thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT jennabemerson thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT ashleydborgstadt thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT lindseybeffa thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT matthewtoliver thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT virginiahovanesian thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT anzeurh thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT rakeshksingh thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT rachaelrowswellturner thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT pauladisilvestro thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT joyceou thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT richardgmoore thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT jenniferrribeiro thebiomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT nicoleejames biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT jennabemerson biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT ashleydborgstadt biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT lindseybeffa biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT matthewtoliver biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT virginiahovanesian biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT anzeurh biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT rakeshksingh biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT rachaelrowswellturner biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT pauladisilvestro biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT joyceou biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT richardgmoore biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
AT jenniferrribeiro biomarkerhe4wfdc2promotesaproangiogenicandimmunosuppressivetumormicroenvironmentviaregulationofstat3targetgenes
_version_ 1718389250499543040